RG7112D
Product Specifications
UNSPSC Description
RG7112D is a potent MDM2 inhibitor with IC50s of 11 nM and >10000 nM and for MDM2-p53 and VHL-HIF1α by binding HTRF assay, respectively. RG7112D is coupled by an amide bond to VHL-Amine, resulting in a bi-functional molecule, YX-02-030. YX-02-03, a MDM2-PROTAC, potently inhibits MDM2-p53 binding (HTRF IC50=63nM). RG7112D can stabilize MDM2 protein and increase p53 protein levels[1].
Target Antigen
MDM-2/p53
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rg7112d.html
Smiles
O=C(CN1CCN(CC1)C(N2[C@](C3=CC=C(C=C3)Cl)([C@](C4=CC=C(C=C4)Cl)(N=C2C5=CC=C(C=C5OCC)C(C)(C)C)C)C)=O)O
Molecular Weight
665.65
References & Citations
[1]Clare M Adams, et al. Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer. Cancer Discov. 2023 May 4;13(5):1210-1229.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-158685/RG7112D-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-158685/
Clinical Information
No Development Reported
CAS Number
2360561-90-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Monoclonal ORP150/HSP12A Antibody (201) [DyLight 755]](https://cdn.genprice.uk/genprice/genprice2.png)
MBS6229963-01 0.1 mL
SMAD7 (SMAD Family Member 7, CRCS3, FLJ16482, MADH7, MADH8) (MaxLight 650)
Ask
View Details 
MBS6229963-02 5x 0.1 mL
SMAD7 (SMAD Family Member 7, CRCS3, FLJ16482, MADH7, MADH8) (MaxLight 650)
Ask
View Details KBH20074 96 Well
GENLISA™ Human Pituitary adenylate cyclase - activating polypeptide type I receptor (ADCYAP1R1) ELISA
Ask
View Details 